Following the announcement of a $4.1 billion acquisition by Patient Square Capital, Patterson Companies (PDCO, Financials) saw its shares soar more than 30% in premarket trading on Wednesday. Given cash values of $31.35 per share, owners should enjoy a clear premium over the firm's current trading price.
Leading distributor of dentistry and animal health goods Patterson Companies reported a clear agreement to be bought by Patient Square Capital, a private equity company with a focus on healthcare. With the sale, the firm is valued at around $4.1 billion and pays cash to each shareholder $31.35 per share.
Subject to regulatory clearances and shareholder assent, the agreement is scheduled to finalize in the fourth quarter of Patterson's fiscal 2025, according a company release.
Ademi LLP, a legal company focused on shareholder rights, has taken notice of the purchase and declared an inquiry on whether Patterson's board behaved in the best interest of public shareholders and obtained a fair price for the deal.
Patterson posted its fiscal second-quarter results on December 5 before the acquisition announcement. With net revenues of $1.67 billiona meager 1.3% rise from the same time previous yearthe business said A cybersecurity hack at Change Healthcare, a third-party vendor, affected profits, hence the firm changed its projection of fiscal 2025 earnings.
This article first appeared on GuruFocus.免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。